APLS vs AMGN: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Amgen Inc in 2026
APLS
Apellis Pharmaceuticals Inc
$40.88
AMGN
Amgen Inc
$345.84
Key Metrics Comparison
| Metric | APLS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $5.22B | $189.19B | AMGN |
| P/E Ratio | 226.94 | 24.70 | AMGN |
| EPS (TTM) | $0.18 | $14.21 | AMGN |
| Revenue Growth | -0.1% | 0.1% | AMGN |
| Gross Margin | 60.3% | 70.8% | AMGN |
Analyze APLS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or AMGN a better investment?
Comparing APLS and AMGN: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and AMGN?
APLS (Apellis Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or AMGN?
Based on P/E ratios, AMGN trades at a lower multiple (24.7x vs 226.9x).
Which is growing faster: APLS or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.1% for APLS.
Which company is more profitable: APLS or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 60.3% for APLS.
Which is the larger company: APLS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $5.22B for APLS.
Should I buy APLS or AMGN in 2026?
Both APLS and AMGN have investment merit. APLS trades at $40.88 while AMGN trades at $345.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and AMGN stock?
Key differences: Market Cap ($5.22B vs $189.19B), P/E Ratio (226.9x vs 24.7x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (60.3% vs 70.8%).